Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ISRCTN92139363) titled 'Evaluation of a novel bowel cancer blood test to prioritise the colonoscopy waiting list' on May 20.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Blinded (masking used)
Control: Uncontrolled
Assignment: Single
Purpose: Diagnostic
Primary Sponsor: Swansea Bay University Health Board
Condition:
Colorectal cancer, high risk polyp and genetic colorectal cancer predispositions
Cancer
Intervention:
Patients on the surveillance colonoscopy waiting list will be invited to provide a blood sample that will be analysed by Raman spectroscopy to determine a risk score for colorectal...